Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows.
77 Biggest Movers From Yesterday
Gainers
TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.
Celldex Announces Acceptance Of Abstract For Barzolvolimab Phase 1b Results In Chronic Spontaneous Urticaria For Late-Breaking Presentation At The European Academy Of Allergy And Clinical Immunology (EAACI) Annual Congress 2022
Celldex Announces Acceptance of Abstract for Barzolvolimab Phase 1b Results in Chronic Spontaneous Urticaria for Late-Breaking Presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual
Celldex Therapeutics Q1 EPS $(0.49) Down From $(0.42) YoY, Sales $200.00K Down From $685.00K YoY
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.49) per share. This is a 16.67 percent decrease over losses of $(0.42) per share from the same period last year. The company reported $200.00 thousand
Celldex Therapeutics Q4 EPS $(0.43) Misses $(0.42) Estimate, Sales $300.00K Down From $3.79M YoY
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.42) by 2.38 percent. This is a 21.82 percent increase over losses of $(0.55) per share
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Celldex Therapeutics Q3 EPS $(0.45) Down From $(0.36) YoY, Sales $153.00K Down From $668.00K YoY
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.45) per share. This is a 25 percent decrease over losses of $(0.36) per share from the same period last year. The company reported $153.00 thousand in
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 4)